Akums Drugs and Pharmaceutical Working Capital to Net Assets Ratio
Akums Drugs and Pharmaceutical working capital to net assets ratio. Akums Drugs and Pharmaceutical (AKUMS) has a Working Capital to Net Assets ratio of 74.0% as of March 2026. Working capital of Rs24.65 Billion (current assets of Rs35.60 Billion minus current liabilities of Rs10.95 Billion) is measured against net assets of Rs33.31 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Akums Drugs and Pharmaceutical tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Akums Drugs and Pharmaceutical (2022–2026)
Working capital to net assets ratio of Akums Drugs and Pharmaceutical from 2022 to 2026. This chart shows how Akums Drugs and Pharmaceutical's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2022 to 2026. As of March 2026, the ratio stands at 74.0%, reflecting working capital of Rs24.65 Billion against net assets of Rs33.31 Billion INR. See Akums Drugs and Pharmaceutical defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Akums Drugs and Pharmaceutical Working Capital to Net Assets Ratio by Year (2022–2026)
Akums Drugs and Pharmaceutical working capital to net assets ratio by year from 2022 to 2026. The table below presents the year-by-year Working Capital to Net Assets ratio for Akums Drugs and Pharmaceutical from 2022 to 2026, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Akums Drugs and Pharmaceutical balance sheet assets.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 74.0% | Rs24.65 Billion | Rs33.31 Billion | Rs35.60 Billion | Rs10.95 Billion | ▲ +28.9 pp |
| 2025 | 45.1% | Rs13.81 Billion | Rs30.64 Billion | Rs22.75 Billion | Rs8.94 Billion | ▼ -56.3 pp |
| 2024 | 101.4% | Rs7.30 Billion | Rs7.20 Billion | Rs19.41 Billion | Rs12.11 Billion | ▲ +10.3 pp |
| 2023 | 91.0% | Rs6.59 Billion | Rs7.23 Billion | Rs19.24 Billion | Rs12.66 Billion | ▼ -8.0 pp |
| 2022 | 99.0% | Rs6.19 Billion | Rs6.25 Billion | Rs18.92 Billion | Rs12.72 Billion | — |